Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis

Carsten Flohr; Alan D. Irvine; Michael J. Cork; Eric L. Simpson; Andreas Wollenberg; Mette Deleuran; Amy Praestgaard; Ryan B. Thomas; Ana B. Rossi

doi:10.1093/bjd/ljad124

Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis

Carsten Flohr, Alan D. Irvine, Michael J. Cork, Eric L. Simpson, Andreas Wollenberg, Mette Deleuran, Amy Praestgaard, Ryan B. Thomas, Ana B. Rossi^*

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	238-240
Number of pages	3
Journal	British Journal of Dermatology
Volume	189
Issue number	2
DOIs	https://doi.org/10.1093/bjd/ljad124
Publication status	Published - Aug 2023

Access to Document

10.1093/bjd/ljad124

Cite this

@article{dcad3ccef4ac454baca809ba9762b1c3,

title = "Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis",

author = "Carsten Flohr and Irvine, {Alan D.} and Cork, {Michael J.} and Simpson, {Eric L.} and Andreas Wollenberg and Mette Deleuran and Amy Praestgaard and Thomas, {Ryan B.} and Rossi, {Ana B.}",

note = "Funding Information: Funding sources: Sanofi and Regeneron Pharmaceuticals Inc. funded the medical writing and editorial assistance provided by Liselotte van Delden, of Excerpta Medica.",

year = "2023",

month = aug,

doi = "10.1093/bjd/ljad124",

language = "English",

volume = "189",

pages = "238--240",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "John Wiley & Sons, Ltd (10.1111)",

number = "2",

}

TY - JOUR

T1 - Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis

AU - Flohr, Carsten

AU - Irvine, Alan D.

AU - Cork, Michael J.

AU - Simpson, Eric L.

AU - Wollenberg, Andreas

AU - Deleuran, Mette

AU - Praestgaard, Amy

AU - Thomas, Ryan B.

AU - Rossi, Ana B.

N1 - Funding Information: Funding sources: Sanofi and Regeneron Pharmaceuticals Inc. funded the medical writing and editorial assistance provided by Liselotte van Delden, of Excerpta Medica.

PY - 2023/8

Y1 - 2023/8

UR - http://www.scopus.com/inward/record.url?scp=85165223262&partnerID=8YFLogxK

U2 - 10.1093/bjd/ljad124

DO - 10.1093/bjd/ljad124

M3 - Letter

C2 - 37120724

AN - SCOPUS:85165223262

SN - 0007-0963

VL - 189

SP - 238

EP - 240

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 2

ER -

Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis

Access to Document

Other files and links

Cite this